A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/56 (2006.01)
Patent
CA 2308406
The present invention is directed to a method for reducing mast cell mediated allergic reactions, including mast cell mediated allergy and asthma. Mast cell mediated allergic reactions, including type I hypersensitivity response to allergens and asthma, are reduced by administering a dehydroepiandrosterone (DHEA) derivative to a patient in a manner which quickly raises blood levels of the active agent.
L'invention porte sur un procédé qui permet d'atténuer des réactions allergiques induites par des mastocytes, y compris l'allergie et l'asthme induits par des mastocytes. Des réactions allergiques induites par des mastocytes, y compris des réactions d'hypersensibilité (type I) aux allergènes et à l'asthme, sont atténuées par administration d'un dérivé de déhydroépiandrostérone (DHEA) à un patient d'une manière propre à augmenter rapidement la concentration sanguine de l'ingrédient actif.
Araneo Barbara A.
Dowell Tad
Norton Steven D.
Gowling Lafleur Henderson Llp
Pharmadigm Inc.
University Of Utah Research Foundation
LandOfFree
Method for reducing mast cell mediated allergic reactions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing mast cell mediated allergic reactions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing mast cell mediated allergic reactions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1494463